Clinical Research & Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Division of Gastroenterology, University of Washington School of Medicine, Seattle, WA, United States of America.
Division of Gastroenterology, University of California, San Francisco, San Francisco, CA, United States of America.
Prev Med. 2019 Jan;118:113-121. doi: 10.1016/j.ypmed.2018.10.021. Epub 2018 Oct 24.
Despite clear evidence that colorectal cancer (CRC) screening reduces mortality, screening, including fecal immunochemical tests (FIT), is underutilized. We conducted a systematic review to determine the evidence of efficacy of interventions to improve FIT completion that could be scaled and utilized in population health management. We systematically searched publication databases for studies evaluating provider- or system-level interventions to improve CRC screening by FIT between 1 January 1996 and 13 December 2017 without language restrictions. Twenty articles describing 25 studies were included, 23 were randomized controlled trials with 1 quasi-experimental and 1 observational study. Ten studies discussed mailed FIT outreach, 4 pre-FIT patient reminders, 3 tailored patient messages, 2 post-FIT reminders, 2 paired FIT with influenza vaccinations, 2 provider alerts and 1 study each described the use of high-quality small media and patient financial incentives. Mailed FIT outreach was consistently effective with median improvement in CRC screening of 21.5% (interquartile range (IQR) 13.6%-29.0%). FIT paired with vaccinations led to a median 15.9% (IQR 15.6%-16.3%) improvement, while pre-FIT and post-FIT reminders demonstrated modest efficacy with median 4.1% (IQR 3.6%-6.7%) and 3.1% (IQR 2.9%-3.3%) improvement in CRC screening, respectively. More than half the studies were at high or unclear risk of bias; heterogeneous study designs and characteristics precluded meta-analysis. FIT-based CRC screening programs utilizing multilevel interventions (e.g. mailed FIT outreach, FIT paired with other preventative services, and provider alerts) have the potential to significantly increase screening participation. However, such programs must also follow-up patients with abnormal FIT results.
尽管有明确的证据表明结直肠癌(CRC)筛查可降低死亡率,但筛查(包括粪便免疫化学测试(FIT))的利用率仍然较低。我们进行了一项系统评价,以确定能够在人群健康管理中推广和利用的提高 FIT 完成率的干预措施的有效性证据。我们系统地搜索了出版物数据库,以评估在 1996 年 1 月 1 日至 2017 年 12 月 13 日期间,通过 FIT 进行 CRC 筛查的提供者或系统水平干预措施的研究,不限制语言。共纳入 20 篇描述 25 项研究的文章,其中 23 项为随机对照试验,1 项为准实验研究,1 项为观察性研究。10 项研究讨论了邮寄 FIT 外展,4 项研究讨论了 FIT 前患者提醒,3 项研究讨论了定制患者信息,2 项研究讨论了 FIT 后提醒,2 项研究讨论了 FIT 与流感疫苗接种相结合,2 项研究讨论了提供者警报,1 项研究描述了使用高质量的小媒体和患者经济激励措施。邮寄 FIT 外展一直是有效的,CRC 筛查的平均改善率为 21.5%(四分位距(IQR)13.6%-29.0%)。FIT 与疫苗接种相结合,平均可改善 15.9%(IQR 15.6%-16.3%),而 FIT 前和 FIT 后提醒的效果适度,CRC 筛查的平均改善率分别为 4.1%(IQR 3.6%-6.7%)和 3.1%(IQR 2.9%-3.3%)。超过一半的研究存在高风险或不确定的偏倚;研究设计和特征的异质性排除了荟萃分析。基于 FIT 的 CRC 筛查计划利用多层次干预措施(例如邮寄 FIT 外展、FIT 与其他预防性服务相结合以及提供者警报)有可能显著提高筛查参与率。然而,此类计划还必须对 FIT 结果异常的患者进行随访。